澳大利亚呼吸生命科学公司于2026年在苏格兰开设联合王国药用大麻设施,创造100个就业机会。 Australian firm Breathe Life Sciences to open UK medicinal cannabis facility in Scotland by 2026, creating 100 jobs.

呼吸生命科学是一家澳大利亚药用大麻公司,计划到2026年底在苏格兰边境地区开设一个制造和分销中心,在三年内创造多达100个工作机会。 Breathe Life Sciences, an Australian medicinal cannabis company, plans to open a manufacturing and distribution center in Scotland’s Borders region by late 2026, creating up to 100 jobs over three years. 该设施不种植大麻,将生产供临床使用的药物,包括pilokocybin和MDMA,由350 000英镑的赠款和来自苏格兰南方企业的500 000英镑贷款提供支持。 The facility, which will not grow cannabis, will produce medicines including psilocybin and MDMA for clinical use, supported by a £350,000 grant and £500,000 loan from South of Scotland Enterprise. 该项目旨在加强联合王国国内供应符合国民保健制度资格的大麻治疗,而该国快速增长的药用大麻市场的需求在不断增长,目前每年的药用大麻价值达2.5亿英镑。 The project aims to strengthen the UK’s domestic supply of NHS-eligible cannabis-based treatments amid rising demand in the country’s fast-growing medicinal cannabis market, now valued at £250 million annually. 在开始运作之前,必须持有内政部许可证。 A Home Office licence is required before operations begin.